• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • 3 Cosmetics Draft Regulations Issued for Public Consultation

3 Cosmetics Draft Regulations Issued for Public Consultation

Friday, 21 August 2020 / Published in Medical Device, News

3 Cosmetics Draft Regulations Issued for Public Consultation

In July 2020, the NMPA (National Medical Products Administration) announced three drafts and launched a public consultation to solicit comments:

Draft of the administrative measures for cosmetics registration and filing in China

  • The draft was announced on July 21, 2020.
  • The public consultation ends on August 20, 2020.
  • What’s New?
    • The requirements of the registrants and filers have been specified:
      • Well-established QMS (Quality Management System)
      • The person in charge of quality and safety should possess more than 5 years of professional experience in quality management or manufacturing of cosmetics
      • Well-established management system for supplier selection, checking of raw materials upon arrival, manufacturing process, quality control, facility equipment, product inspection, etc.
      • Well-established safety risk assessment, adverse events monitoring, and recall policy for cosmetics
    • The filers should submit the annual report of the products manufactured and imported, as well as the adverse events monitoring report every year to their respective MPA (Medical Products Administration) in China. 
    • During the technical review process, if any false information has been identified in the application submitted, a local or overseas on-site inspection may be required, but subjected to the actual circumstances.

Draft of the classification rules and catalogue

  • The draft was announced on July 29, 2020.
  • The public consultation ends on August 30, 2020.
  • The classification catalogue was drafted in detail according to:
    • Efficacy claims
    • Body parts
    • Product forms
    • Age groups
    • Usage

Draft of the technical guidelines for the safety assessment on cosmetics

  • The draft was announced on July 29, 2020.
  • The public consultation ends on August 30, 2020.
  • Highlights of the draft for the safety assessment procedures of cosmetics include, but not limited to the following:
    • Scope of application
    • Basic Principles and requirements
    • Requirements of the safety assessment inspector
    • Risk evaluation procedures
    • Toxicology of cosmetics
    • Risk evaluation of raw materials
    • Post-market surveillance
    • Safety assessment report

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Public Consultation

What you can read next

NMPA Essential Principles of Safety and Performance of Medical Devices
NMPA Finally Updates IVD Reagent Classification
Draft of TSG 22 for mobile pressure vessels published for comments

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Updates on the Medical Device Classification Catalogue in China

    On December 31, 2020, the NMPA announced (No.14...
  • Cisema Partners with Advamed

    Cisema is delighted to announce it is now an as...
  • Guidelines for Sampling Testing on Organic Foods

    On December 4, 2020, the CNCA (Certification an...
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

    On January 22, 2021, the NIFDC (China National ...
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

    China Regulatory Guidelines Issued / Updated Th...

Archive

Cisema

With nine locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2019 Cisema. All rights reserved.

TOP